glp-1 prescriptions growth slowing 2024 drugs are rewriting America's food preferences, says IFF GLP-1 Receptor Agonist Market Size

This Comment highlights emerging evidence and advocates for clinical strategies that prioritize muscle preservation to ensure the long-term success and safety of pharmacological weight management

My whole life was thinking about food, says Meranda Hall, a 33-year-old administrator at a law firm in New York City

Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates

It is important to separate the class mechanism from labeled indication

65 Early investigations revealed that SSc patients exhibited higher levels of CD4+ DPP4+ T cells in their peripheral blood, and DPP4 activity in T cells was associated with disease severity